POST-ACUTE COVID-19
Clinical trials for POST-ACUTE COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST-ACUTE COVID-19 trials appear
Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an antiviral pill ease long COVID? new trial hopes so.
Disease control OngoingThis study tests whether the antiviral drug ensitrelvir can help people with long COVID by targeting leftover virus in the body. About 40 adults with long COVID symptoms will receive either the drug or a placebo for 10 days. The main goal is to see if the drug improves physical h…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Could an antibody ease long COVID? new study investigates
Symptom relief OngoingThis study tests whether a lab-made antibody called AER002 can safely help people with Long COVID feel better. Researchers think that leftover virus pieces in the body might cause Long COVID, and this antibody aims to target them. The trial involves 36 adults who receive either t…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Symptom relief
Last updated May 26, 2026 05:27 UTC